Post-Market Study of The Tripod-Fix Vertebral Body Augmentation System in Osteoporotic Vertebral Compression Fractures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

53 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-16

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this Post-Market Clinical Follow-Up Study is to evaluate the safety and performance of the Tripod-Fix in the treatment of vertebral compression fractures (VCF) resulting from osteoporosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study on the Treatment of Osteoporotic Vertebral Fractures Using Vertebral Body Stenting

NCT01847898

Vertebral Body Fractures

COMPLETED PHASE4

Vertebral Augmentation Using VCFix Spinal System in Stand-alone Configuration

NCT07259811

Vertebral Compression Fracture

ACTIVE_NOT_RECRUITING NA

Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.

NCT05312281

Spinal Stenosis

RECRUITING NA

Clinical Outcome Measure at Stryker Spine

NCT06226272

Degenerative Disc Disease Degenerative Scoliosis

NOT_YET_RECRUITING

Study Using the SpinalStim Device Following Lumbar Fusion Surgery

NCT03176303

Lumbar Spine Degeneration

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a prospective, multicenter, open-label, single-arm, PMCF study. The sample size for this study will be 50 patients. Eligible patients will be treated with Tripod-Fix on Day 0 and will be followed for a total of 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporotic Vertebral Compression Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Tripod-Fix will be used to treat osteoporotic vertebral compression fractures.

Group Type EXPERIMENTAL

Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix)

Intervention Type DEVICE

The Tripod-Fix is a permanent implant used for vertebral augmentation in patients with osteoporotic vertebral compression fractures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tripod-Fix Vertebral Body Augmentation System (Tripod-Fix)

The Tripod-Fix is a permanent implant used for vertebral augmentation in patients with osteoporotic vertebral compression fractures.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Provision of signed and dated informed consent form prior to any study procedures
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Skeletally mature males and females
4. 1 painful VCF which meets all of the following criteria:

1. Fracture due to diagnosed or presumed underlying osteoporosis (T-score \< -2.5 points)
2. VCF between T6 and L5
3. VCF shows loss of height in the anterior, mid or posterior third of the vertebral body from an estimated pre-fracture configuration, but no more than 50% based on X-ray, CT or MRI at baseline.
4. The Index fracture is acute or persistent (not healed), as demonstrated by MRI (or bone scan if the patient is contraindicated for MRI).
5. Investigator believes target vertebral body is suitable for Tripod-Fix procedure (e.g., appropriate pedicle diameter) assessed on radiography preoperative.

Exclusion Criteria

Tripod-Fix is not indicated for any other application other than that for which it is designed. contraindications for Tripod-Fix include, but are not limited to: .

1. Patient presenting a loss of vertebral height \>50% compared to estimated pre-fracture height
2. Sclerotic fracture
3. Patient with a prior history of intolerance or of allergic reaction to titanium and/or one of the components of the PMMA cement
4. Patient suffering from irreversible coagulopathy or undergoing anticoagulant treatment at the moment of surgery or at least 8 days prior to inclusion
5. Active infection (systemic or in the target vertebra)
6. Patient suffering from a severe or uncontrolled systemic disease
7. Patient presenting a pathological fracture with the presence of a mass within the spinal canal
8. Patient presenting neurological damage caused by vertebral fracture
9. Patient pregnant or likely to be so or breastfeeding
10. Patient vertebral anatomy not compatible with the size of the implant or instrumentation
11. Fracture geometry making the insertion of the implant impossible

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No